Azenta Secures Full Repayment of $35M Loan from B Medical Systems…

Event summary

Azenta received full repayment of $35M vendor loan from Thelema S.à r.l., securing the entire $63M purchase price for B Medical Systems.
The loan, extended in connection with the sale of B Medical Systems, was repaid prior to maturity along with accrued interest.
The transaction closed on July 1, 2026, with Azenta Germany GmbH providing the secured term loan.
The repayment completes the divestiture of B Medical Systems, eliminating credit exposure for Azenta.

The big picture

Azenta's full repayment of the $35M vendor loan underscores its disciplined approach to capital allocation and risk management. The completion of the B Medical Systems divestiture aligns with broader industry trends of portfolio optimization and strategic refocusing. With the entire $63M purchase price now in cash, Azenta can prioritize investments in its core life sciences solutions and multiomics services, positioning itself for sustained growth in a competitive market.

What we're watching

Capital Allocation: How Azenta will deploy the $63M proceeds from the B Medical Systems sale to support its strategic initiatives.
Credit Risk: Whether the elimination of credit exposure will enhance Azenta's financial flexibility and stability.
Divestiture Strategy: The pace at which Azenta will pursue further divestitures to streamline its portfolio and focus on core businesses.